Alpha 2.0
Login Register
» Articles » PMID: 7972227

3F8 Monoclonal Antibody Treatment of Patients with Stage IV Neuroblastoma: a Phase II Study

Overview
Journal Prog Clin Biol Res
Specialties Biology
General Medicine
Date 1994 Jan 1
PMID 7972227
Citations 5
Authors
N K Cheung
B H Kushner
S J Yeh
S M Larson
Affiliations
Soon will be listed here.
Citing Articles

Using a combination of gangliosides and cell surface vimentin as surface biomarkers for isolating osteosarcoma cells in microfluidic devices.

Fasanya H, Dopico P, Yeager Z, Fan Z, Siemann D J Bone Oncol. 2021; 28:100357.

PMID: 33912384 PMC: 8065304. DOI: 10.1016/j.jbo.2021.100357.

New aspects of neuroblastoma treatment: ASPHO 2011 symposium review.

Zage P, Louis C, Cohn S Pediatr Blood Cancer. 2012; 58(7):1099-105.

PMID: 22378620 PMC: 4104176. DOI: 10.1002/pbc.24116.

Strategies for the targeted delivery of therapeutics for osteosarcoma.

Hughes D Expert Opin Drug Deliv. 2009; 6(12):1311-21.

PMID: 19761419 PMC: 4163784. DOI: 10.1517/17425240903280422.

Intratumoral immunocytokine treatment results in enhanced antitumor effects.

Johnson E, Lum H, Rakhmilevich A, Schmidt B, Furlong M, Buhtoiarov I Cancer Immunol Immunother. 2008; 57(12):1891-902.

PMID: 18438664 PMC: 2574976. DOI: 10.1007/s00262-008-0519-0.

Biosynthesis and functions of gangliosides: recent advances.

LLOYD K, Furukawa K Glycoconj J. 1999; 15(7):627-36.

PMID: 9881769 DOI: 10.1023/a:1006924128550.